A lawyer of Pharmally Pharmaceutical Corp. on Wednesday criticized the preliminary findings of the Senate Blue Ribbon Committee on the government’s controversial procurement of pandemic supplies.
“I would like to express my concern as to why there is a piecemeal release by the Senate blue ribbon committee of the findings with respect to Pharmally,” Ferdinand Topacio, the counsel of detained company director Lincoln Ong, said in a virtual media forum.
On Tuesday, Senator Richard Gordon, chairman of the panel released a partial report recommending the filing of criminal charges against Ong, other Pharmally officials, former budget Undersecretary Christopher Lloyd Lao, Overall Deputy Ombudsman Warren Liong, and former economic adviser Michael Yang.
Senators are investigating the government’s spending of its Covid-19 response fund. At the center of the controversy is Pharmally, a small firm awarded with the government’s biggest contracts despite being months old and having a paid-up capital of only P625,000.